18:03 02.12.2007, Sex differences in the clinical
Sex differences in the clinical, immunological and virological parameter of HIV-infected patients treated with HAART. Julio Collazos et al AIDS 21:pp 835-843
18:02 02.12.2007, Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome
Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome. Carl Crunfeld, MD, PHD, et al J Acquire Immune Deficiency Syndrome. Volume 45 Number 3 pp.286-291.
18:01 02.12.2007, HIV-positive patients with nonalcoholic fatty liver disease
HIV-positive patients with Non-alcoholic Fatty Liver Disease Have a Lower Body Mass Index and ARE More Physically Active Than HIV-Negative Patients Saira S. Mohammed, BHE, MSc. et al J. Acquir Immune Defic Syndrd. Volume 45 e, Number 4, August 1, 2007
17:59 02.12.2007, HIV and Metabolic Syndrome
HIV and Metabolic Syndrome A comparison with the General Population Paolo Bonfanti, MD, et al J. Acquir Immune Defic Syndr. Volume 45, Number 4 August 7, 2007.
17:58 02.12.2007, Association of HIV-l replication Capacity wilth Treatment Outacomes in Patients
Application of HIV-1 replication Capacity with Treatment Outcomes in Patients with Virologic Treatment Failure. Andrea De Luca, MD, et al J Acquir Immune Defic. Syndr. Volume 45, Numer 4, August 1, 2007
17:57 02.12.2007, Flash-Heat Inactivation in HIV-1 in Human Milk
Flash-Heat Inactivation of HIV-I in Human Milk by Kiersten Israel Ballard MPH-et al J Acquir Immune Defic Syndr. Volume 45, Number 3, July 1, 2007.
17:55 02.12.2007, Early Response to Highly Active Antiretroviral Therapy in Kenyan Children
This study is from Africa. It involves young children. It involves children who had already have severe immunosupression The agents used the classic recommendations of the CDC, 2 nrti's and an nnrti, in this case Nevirapine.
17:54 02.12.2007, Relation Between Symptoms, Viral Load, and Viral Load Set point in Primary HIV
The Protective effecd of Circumcision on HIV incidence in Rural Low-Risk Men-Circumcised Predominantly by Traditional Circumcisers in Kenya (a 2 year follow up of the Kericho HIV Cohort Study
17:52 02.12.2007, Relation Between Soymptoms, Viral Load, and Viral Load Set point in Primary HIV
The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV infection. Colleen F. Kelley, MD, et al J Acquir Immune Defic Syndr 2007:45 Volume 45, Number 4 August 1, 2007
17:51 02.12.2007, Circulating Tcells with regulatory cell phonotype
Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-in vivo. Gareth J. Hughes et al AIDS Volume 21 Number 12 pp. l507-1513.
17:49 02.12.2007, Dietary fat intake and llipid levels in HIV patients
Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
17:47 02.12.2007, Dietary fat intake and llipid levels in HIV patients
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.
17:46 02.12.2007, Barriers to offering HIV testing in an antenatal setting
What are the barriers to offering HIV testing in an antenatal setting? A national Study of obstetricians Michelle L. Giles et al (Australia.AIDS 2007, 21:1601-l606
17:44 02.12.2007, Why don't physicians test for HIV? A review of the US literature
Why don't physicians test for HIV A review f the US literature. Ryan C. Burke et al AIDs Volume 21 Number 12 ppl617-l624.
17:42 02.12.2007, Determinants of virologic and Immunologic Outcomes in patients undergoing STI
Why don't physicians test for HIV A review f the US literature. Ryan C. Burke et al AIDs Volume 21 Number 12 ppl617-l624.
17:40 02.12.2007, Predicting the impact of a partially effectivie Effective HIV Vaccine
HIV-infected Adults with a CD4 Cell Count Greater than 500 cells/mm3 on long-term Combination Antiretroviral therapy reach same mortality rates as the general population.
17:37 02.12.2007, Predicting the impact of a partially effectivie Effective HIV Vaccine
Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Law and Middle Income Countries.
17:34 02.12.2007, Cost effectiveness of Alternate Strategies for Starting ART in Africa
Cost Effectiveness of Alternative strategies for Initiating and Monitoring Highly Active Antiretroviral Therapy in the Developing World. Arthi Vijayaraghavan et al. J Acquir Defic Syndr. Volume 46, Number 1 September 1, 2007. pp 91-100,
17:21 02.12.2007, Stopping Antiretroviral Therapy
The issue directed to in this paper is if necessary how to stop antiretroviral therapy.
17:06 02.12.2007, Rate of AIDS or death in patients on ARV therapy-naive with high CD4 count
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count The UK collaborative HIV Cohort (CHIC) study steering Committee. AIDS Volume 21 Number 13 ppl7l7-l721.
16:59 02.12.2007, DAVID HO MD publicy announces his support for Early treatment of HIV
DAVID HO MD. Director and CEO of the Aaron Diamond Research Center and leading basic scientist and clinical physician of HIV-AIDS patients publicly announced his support for early treatment of Naive HIV + patients.